Let's return to our initial question: Should you buy stocks if a recession is coming in 2026? If history is an guide, the ...

Which group of individuals is in the best position to spot early warning signs of economic trouble? There's a good case to be made for corporate chief financial officers (CFOs). These executives know ...

The debate over whether the U.S. is heading into a recession in 2025 is intensifying, with economists, policymakers and business leaders offering conflicting perspectives. While some indicators ...

Mark Zandi, chief economist at Moody’s Analytics, recently warned that the economy is on the brink of entering a recession, as reported by Newsweek. GOBankingRates spoke with financial experts who ...

As Wall Street grapples with the increasing likelihood of a U.S. recession, the Trump administration has gone to bat defending President Donald Trump’s stock market-slamming trade policies. The S&P ...

Recession risks are on the rise. Impending trade wars, accelerating layoffs, declining consumer confidence, and a stock market correction have Americans understandably skittish. According to Google ...

Recession has been a term thrown around a lot in the past several years. Even though the stock market is back near record highs, trade tariffs, continued inflationary concerns and unknown effects from ...

How is the economy doing? It's a question that many of us are asking, given all of the uncertainty created by President Trump's tariffs. Should we spend money or tighten our belts? The answer to that ...

For months, people have been talking about indicators of the dreaded R-word: recession. There have been the usual suspects: economists, investors, businesspeople and journalists. But maybe the most ...

Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. Yuki ...

Like most utility stocks, Dominion Energy should hold up well during a recession. Vertex Pharmaceuticals' therapies will continue to enjoy strong demand regardless of what happens with the economy.